INSIGHTS ON DOWNSTREAM MANUFACTURING
-
How To Select The Right Platform For Your Vaccine Production Process
Evaluate surface treatments, scalability, and contamination risks to select the right adherent platform. Testing early ensures a seamless transition from benchtop to production.
-
Why Flexible, Tailored CDMO Support Is A Non-Negotiable In Sterile Fill-Finish
Modern injectable programs require adaptable manufacturing strategies. Learn how flexibility, technical depth, and collaboration reduce complexity, manage change, and protect long‑term supply.
-
Optimize Time, Space and Cost With Inline Buffer Formulation And System
Discover how integrating inline buffer formulation with chromatography reduces buffer waste by 50% and delivers a 710% ROI, transforming downstream efficiency and sustainability.
-
Evaluation Of TFF Operating Control Strategies And Scalability
Gain insight into a comparison of TMP and permeate control strategies for viral vector TFF, highlighting impacts on flux, processing time, impurity removal, and scale-up predictability across development.
-
The Effect Of Conventional Cooling Versus Controlled Ice Nucleation On Primary Drying Time4/1/2026
See how controlled ice nucleation shortens lyophilization cycles, supports higher drying temperatures, and reduces complexity for amorphous and mixed formulations without sacrificing quality.
-
Performing Virus Clearance Studies With Retroviral-Like Particles: Updated Guidance3/26/2026
Updated regulatory standards now support using non-infectious retroviral-like particles for viral clearance. This shift reduces costs and accelerates timelines for biomanufacturers.
-
A Gentler Workflow: Fc-fusion Protein Purification With Mixed-Mode And Anion Exchange Chromatography3/26/2026
Gain insights into comparative performance, workflow flexibility, and practical considerations for implementing a new weak anion exchange hydrophobic resin and a strong anion exchange resin.
-
WuXiHigh 2.0 Delivers A 180 mg/mL Formula3/26/2026
This case study shows how smart formulation and integrated development achieved a stable 180 mg/mL biologic for subcutaneous delivery, for teams tackling concentration issues.
-
Tool Enzymes For Antibody-Drug Conjugate Development And Manufacturing3/26/2026
See how modern tool enzymes enable cleaner, more consistent ADC conjugation, sharper analytics, and a smoother path from research to clinical development — practical guidance for manufacturing.
DOWNSTREAM MANUFACTURING SOLUTIONS
-
A pre-verified delivery platform eliminates redundant testing, simplifies regulatory submissions, and optimizes inventory management, allowing teams to focus on drug-specific performance.
-
Leverage a pre-verified, integrated syringe platform. Accelerate timelines and reduce costs by eliminating drug-independent testing while streamlining regulatory submissions through one source.
-
Lightly used Bausch Advanced Technologies isolated filling and closing machine, type 515, currently set up for 5mL BD Luer Syringes and Luer Caps, speeds up to 30/minute. Capable of handling 1mL to 30mL syringes with change parts at additional cost, 3 phase, 208 volt, 60 hertz, 14 kw, serial# 515031, built 2021.
-
Unused Watson-Marlow Flexicon (WMFTS) vial filler, Type Cellefill Ibio, designed for biohazard applications (OEB Level 3-4). Fills up to 25 vials per minute with Flexicon integrated peristaltic pump infeed. Features IPC via built-in load cell with automatic feedback, stoppering, and crimp capping for flip-top caps with built-in force measurement. Pick-and-place discharge, EM monitoring, SQL database data collection, and automatic vial size adjustment. Built 2022.
-
Unused Groninger Aseptic Vial Filling Line, speeds up to 150 vials/minute. Line is designed to CE-norms. Set up for 3 mL, 5 mL with 13mm neck size, 10R, 10Ml, with 20mm neck size, speeds up to 150 vials/minute, 20H, with 20mm neck size, speeds up to 60 vials/minute, and 30mL with 20mm neck size range, speeds up to 50 vials/minute.